Treatment
Lumason clinical trials
We’re tracking 7 recruiting studies that include Lumason, each written for real people, not researchers, below.
Recruiting studies
- NCT06400004RecruitingPhase 3
Lumason infusion vs. bolus for better heart imaging
This trial compares two ways of giving Lumason (an ultrasound contrast agent) to improve images of the left ventricle in people whose initial heart ultrasound was unclear. It may help those with a 'suboptimal' view of the heart's pumping chamber.
West Hills, CaliforniaAges 18 years+ - NCT07664176RecruitingPhase 1
Focused ultrasound plus nivolumab for children with brain tumors
This trial tests if combining focused ultrasound (which opens the blood-brain barrier) with the immunotherapy drug nivolumab can treat relapsed or progressive brainstem gliomas and other high-grade brain tumors in children and young adults.
Washington D.C., District of ColumbiaAges 3–25 - NCT07145801RecruitingPhase 2
Y-90 treatment response for liver cancer
This trial tests how well a Y-90 radiation treatment works for liver cancer that hasn't been treated before. It uses ultrasound imaging to check the response.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06693752RecruitingPhase 2
Ultrasound test for fluid on the brain in babies
This trial uses a special ultrasound with contrast to study fluid on the brain (hydrocephalus) in newborn babies. The aim is to learn more about the condition and improve treatment options.
Philadelphia, PennsylvaniaAges 1 minute–1.5 years - NCT05569122RecruitingPhase 1
Studying an MRI contrast method in mitochondrial muscle disease
This Phase 1 study tests a special MRI approach (using a contrast agent) to better measure changes in muscles in people with mitochondrial diseases. It also includes some healthy volunteers and other critically ill patients to compare results and check safety.
Philadelphia, PennsylvaniaAges 10–60 - NCT03490929RecruitingPhase 4
Ultrasound contrast test for abdominal injuries in children
This trial checks whether a special ultrasound (with contrast) can help doctors evaluate blunt abdominal injuries in children. It may reduce the need for rushed decisions by improving how internal injuries are seen quickly and safely.
Rochester, MinnesotaAges birth–17 years - NCT03107520RecruitingEarly Phase 1
Ultrasound during hip surgery to check blood flow
This early-phase study tests a special ultrasound with an added contrast medicine (Lumason) during surgery for babies with developmental dysplasia of the hip (DDH). It aims to better see blood flow at the time of surgery, which may help guide and improve care.
Philadelphia, PennsylvaniaAges 4 months–2 years
What Lumason is being studied for
Conditions with recruiting Lumason studies.
Common questions
- Are there clinical trials studying Lumason?
- Yes. Clin2 currently lists 7 recruiting studies that include Lumason, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Lumason trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Lumason an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Lumason or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.